Ulisse Biomed launches a new phase of growth
2025-10-22
Ulisse Biomed reports 40% revenue growth and a new strategic phase, backed by €10M from U.S. investors to boost global expansion and innovation.continua…
Ulisse Biomed reports 40% revenue growth and a new strategic phase, backed by €10M from U.S. investors to boost global expansion and innovation.continua…